Skip to main content
. 2020 May 14;26(18):2138–2154. doi: 10.3748/wjg.v26.i18.2138

Figure 2.

Figure 2

Proposal of a treatment algorithm for low-density lipoprotein cholesterol lowering strategy in liver transplant recipients. 1Class of recommendation: IIa; level of evidence: B, according to 2019 ESC/EAS Guidelines for the management of dyslipidaemias[118]. 2Class of recommendation: IIb; level of evidence: C, according to 2019 ESC/EAS Guidelines for the management of dyslipidaemias[118]. LDL-C: Low-density lipoprotein cholesterol.